Emgality Side Effects
Generic name: galcanezumab
Note: This document provides detailed information about Emgality Side Effects associated with galcanezumab. Some dosage forms listed on this page may not apply specifically to the brand name Emgality.
Applies to galcanezumab: subcutaneous solution.
Common side effects of Emgality
Some side effects of galcanezumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- bleeding, blistering, burning, coldness, discoloration of skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
Serious side effects of Emgality
Along with its needed effects, galcanezumab (the active ingredient contained in Emgality) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking galcanezumab:
Incidence not known
- difficulty breathing
- fast heartbeat
- fever
- hives, itching, skin rash
- hoarseness
- irritation
- joint pain, stiffness, or swelling
- redness of the skin
- swelling of the eyelids, face, lips, hands, or feet
- tightness in the chest
- trouble with swallowing
For healthcare professionals
Applies to galcanezumab: subcutaneous solution.
General
The most commonly reported adverse reaction has been injection site reactions.[Ref]
Hypersensitivity
- Frequency not reported: Hypersensitivity reactions (including dyspnea, urticaria, and rash)
- Postmarketing reports: Anaphylaxis, angioedema[Ref]
Immunologic
- Very common (10% or more): Anti-Drug-Antibodies (up to 12.5%)[Ref]
Local
- Very common (10% or more): Injection site reactions (18%)[Ref]
Injection site reaction included event terms such as injection site pain, injection site reaction, injection site erythema, and injection site pruritus.[Ref]
Other
- Common (1% to 10%): Vertigo
Dermatologic
- Common (1% to 10%): Pruritus
- Uncommon (0.1% to 1%): Urticaria
- Postmarketing reports: Rash
Gastrointestinal
- Common (1% to 10%): Constipation
References
1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
2. Cerner Multum, Inc. "Australian Product Information."
3. (2018) "Product Information. Emgality (galcanezumab)." Lilly, Eli and Company
Frequently asked questions
- What are the new drugs for the treatment of migraines?
- Does it cause weight gain?
- How long does it take to work?
- Do the injections hurt?
- How does it work?
- Does injecting Emgality cause a reaction?
- How do I inject Emgality? Step by step guide
- Does Emgality cause hair loss?
- How long can Emgality be out of the fridge?
More about Emgality (galcanezumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (479)
- Drug images
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: CGRP inhibitors
- Breastfeeding
Patient resources
Professional resources
Related treatment guides
Further information
Emgality side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.
